With a revenue increase of 19.91% in the second quarter 2026, year on year to cumulative value of $3,407 million, Biomarin Pharmaceutical Inc's revenue per employee grew on a trailing twelve months basis to $ 1,057,626, this marks a new company high. Within the Healthcare sector Employees of 76 other companies have achieved higher revenue per employee. While Biomarin Pharmaceutical Inc's total ranking has deteriorated compared to the previous quarter from 344 to 851. Biomarin Pharmaceutical Inc has 3,221 employees.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.